Twitter | Search | |
Servier
We are engaged with and for the , from to providing therapeutic .
2,105
Tweets
478
Following
3,724
Followers
Tweets
Servier Jun 14
Servier has 3 Research Institutes, 2 in and 1 in . 👉
Reply Retweet Like
Servier Jun 14
how much of the world’s population is affected by signs and symptoms of ?
Reply Retweet Like
Servier Jun 13
The Mécénat Servier Charity Fund launched its first ever Joint Initiatives. 2️⃣ finalists were nominated and based on their approach to help local communities!
Reply Retweet Like
Servier Jun 12
Dr. Philippe Gonnard, our Executive Vice President in Global Medical Affairs, outlines our commitment on the objectivity and ethics of the information delivered to health care professionals. 👉
Reply Retweet Like
Servier Jun 12
With this new site on , Servier whishes to facilitiate access to medical training by making available: 📌Useful tips and tricks for best practice 📻Interviews and Podcasts 📽️Library with videos, books 🗞️Latest news on venous diseases
Reply Retweet Like
Servier retweeted
G5 Santé Jun 12
Les propositions du G5 Santé pour enrayer le recul de la France dans la - Etude
Reply Retweet Like
Servier retweeted
G5 Santé Jun 12
Sans les entreprises du G5, la balance commerciale de la France serait déficitaire - LT Etude BIPE
Reply Retweet Like
Servier retweeted
G5 Santé Jun 12
Y L’Epine, Président G5 : Pourquoi cette étude BIPE ? Après des années de régulation forte des dépenses de santé pesant sur les dépenses d’assurance maladie, la France n’est plus un grand pays d’industries de santé, et recule par rapport aux pays voisins - LT
Reply Retweet Like
Servier Jun 10
Servier and complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients.
Reply Retweet Like
Servier Jun 10
The Group has decided to focus its on three major immuno-inflammatory diseases: ▶️systemic lupus erythematosus, ▶️systemic scleroderma ▶️Sjögren's syndrome
Reply Retweet Like
Servier Jun 7
Nearly 1.4 M cases of are detected every year. Regular check-ups will help catch early .
Reply Retweet Like
Servier Jun 7
Servier has been involved in for 50 years! The Group has just launched a single access portal approved by international experts in the field of and . 👉
Reply Retweet Like
Servier Jun 6
6th June is World Anti-Counterfeiting Day! For 15 years, Servier has been at the forefront fighting against the sale of fake medicines. Find the interview of Wilfrid Roge, our Head of fight against falsification at Servier! ➡️
Reply Retweet Like
Servier Jun 6
A very successful partnering convention for Servier’s BD team ! A partnership with Servier means working closely with dedicated capable of implementing and developing alliances in over 90 .
Reply Retweet Like
Servier Jun 6
Servier appoints for lentiviral vector GMP-manufacturing in CAR-T cell development technology ➡️
Reply Retweet Like
Servier Jun 6
To meet the health care challenges of tomorrow, the Group has set up research partnerships with the contributions of , and . 👉
Reply Retweet Like
Servier Jun 5
Meet Dr Marianne De Maeseneer on the new Servier website dedicated to and 👉
Reply Retweet Like
Servier retweeted
Yposkesi Jun 5
Yposkesi and sign lentiviral GMP-manufacturing service agreement in support of Servier's allogenic CAR-T cell technology development:
Reply Retweet Like
Servier Jun 5
Dr. Emmanuel Canet, Senior Executive Vice President in Research and Development, shares a few words about our new and original lines of . 👉
Reply Retweet Like
Servier Jun 4
Are you at ? Learn more about who we are and why we partner with Servier, Vice President, Global Head of BD&L, E. Falcand in Theater 1 at 10:45 AM today, and meet with the whole team at 4:00 PM for a special event in the French Pavilion!
Reply Retweet Like